David Marcilla

417 total citations
17 papers, 136 citations indexed

About

David Marcilla is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Marcilla has authored 17 papers receiving a total of 136 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 7 papers in Rheumatology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Marcilla's work include Sarcoma Diagnosis and Treatment (12 papers), Cardiac tumors and thrombi (4 papers) and Bone Tumor Diagnosis and Treatments (4 papers). David Marcilla is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Cardiac tumors and thrombi (4 papers) and Bone Tumor Diagnosis and Treatments (4 papers). David Marcilla collaborates with scholars based in Spain, Italy and Germany. David Marcilla's co-authors include Enrique de Álava, Juan Díaz‐Martín, Israel Fernández‐Pineda, José Bernabéu‐Wittel, Laura Romero‐Pérez, Lourdes Hontecillas‐Prieto, Daniel J. García-Domínguez, Thomas G. P. Grünewald, Nadia Hindi and Gema Ramírez and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and International Journal of Molecular Sciences.

In The Last Decade

David Marcilla

15 papers receiving 136 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Marcilla Spain 7 61 44 38 37 29 17 136
Phani K. Davineni United States 6 63 1.0× 40 0.9× 46 1.2× 26 0.7× 28 1.0× 6 160
Corey D. Chan United Kingdom 6 90 1.5× 23 0.5× 56 1.5× 28 0.8× 25 0.9× 16 144
Salma Adham France 8 58 1.0× 32 0.7× 31 0.8× 46 1.2× 35 1.2× 23 213
Alethia Álvarez‐Cano Mexico 6 70 1.1× 54 1.2× 110 2.9× 11 0.3× 47 1.6× 10 175
Hélène Boutroux France 9 94 1.5× 48 1.1× 37 1.0× 14 0.4× 32 1.1× 21 171
Yoshiyuki Nagumo Japan 8 64 1.0× 35 0.8× 35 0.9× 91 2.5× 75 2.6× 48 238
Bérengère Dadone‐Montaudié France 7 73 1.2× 14 0.3× 56 1.5× 10 0.3× 39 1.3× 23 146
Annick Chevalier-Place France 6 48 0.8× 12 0.3× 56 1.5× 27 0.7× 33 1.1× 7 148
Ka Su China 7 76 1.2× 19 0.4× 71 1.9× 81 2.2× 94 3.2× 10 264
Stuart Cramer United States 7 32 0.5× 12 0.3× 55 1.4× 51 1.4× 28 1.0× 12 151

Countries citing papers authored by David Marcilla

Since Specialization
Citations

This map shows the geographic impact of David Marcilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Marcilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Marcilla more than expected).

Fields of papers citing papers by David Marcilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Marcilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Marcilla. The network helps show where David Marcilla may publish in the future.

Co-authorship network of co-authors of David Marcilla

This figure shows the co-authorship network connecting the top 25 collaborators of David Marcilla. A scholar is included among the top collaborators of David Marcilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Marcilla. David Marcilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zaldumbide, Laura, et al.. (2024). Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms. International Journal of Molecular Sciences. 25(3). 1735–1735. 6 indexed citations
2.
Martín‐Broto, Javier, Jerónimo Martínez-García, David S. Moura, et al.. (2023). Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A. Signal Transduction and Targeted Therapy. 8(1). 405–405. 15 indexed citations
3.
Martín‐Broto, Javier, Andrés Redondo, David S. Moura, et al.. (2022). A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors. Nature Communications. 13(1). 6278–6278. 2 indexed citations
4.
Almeida, C., et al.. (2022). Myxoid liposarcoma: MRI features with histological correlation. Radiología (English Edition). 65. S23–S32. 5 indexed citations
5.
Martín‐Broto, Javier, David S. Moura, Andrés Redondo, et al.. (2022). Phase II trial of palbociclib in advanced sarcoma overexpressing CDK4 gene excluding dedifferentiated liposarcoma (DD LPS): A study from the Spanish Group for Research on Sarcoma (GEIS).. Journal of Clinical Oncology. 40(16_suppl). 11511–11511. 3 indexed citations
6.
7.
Almeida, C., et al.. (2021). Liposarcoma mixoide: características por resonancia magnética con correlación histológica. Radiología. 65. S23–S32. 1 indexed citations
8.
Hindi, Nadia, Antonio Gutiérrez, Inmaculada del Rincón, et al.. (2020). Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center. Cancers. 12(12). 3740–3740. 15 indexed citations
9.
10.
Romero‐Pérez, Laura, Ana Teresa Amaral, David Marcilla, et al.. (2019). Hippo pathway effectors YAP1/TAZ induce an EWS–FLI1 ‐opposing gene signature and associate with disease progression in Ewing sarcoma. The Journal of Pathology. 250(4). 374–386. 21 indexed citations
11.
Hindi, Nadia, Rafael Ramos, Javier Martínez‐Trufero, et al.. (2018). Prognostic role of HMG proteins in a series of 301 advanced soft tissue sarcoma patients: A Spanish Group for Sarcoma Research Study (GEIS).. Journal of Clinical Oncology. 36(15_suppl). 11573–11573. 1 indexed citations
12.
García‐Escudero, Antonio, et al.. (2017). Expression of dog1 in low-grade fibromyxoid sarcoma: A study of 19 cases and review of the literature. Annals of Diagnostic Pathology. 30. 8–11. 7 indexed citations
13.
Martín‐Broto, Javier, David Marcilla, Rafael Ramos, et al.. (2017). Predictive role of FAS for trabectedin in second lines of advanced soft tissue sarcoma (ASTS): A Spanish group for research on sarcoma (GEIS) study.. Journal of Clinical Oncology. 35(15_suppl). 11071–11071. 2 indexed citations
14.
Hontecillas‐Prieto, Lourdes, Daniel J. García-Domínguez, David Marcilla, et al.. (2017). Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients. Oncotarget. 8(7). 11173–11186. 13 indexed citations
15.
Machado, Isidro, David Marcilla, Julia Cruz, et al.. (2016). Protocolo para el estudio de muestras y estandarización del informe patológico de tumores óseos. Revista Española de Patología. 50(1). 34–44.
16.
Álava, Enrique de & David Marcilla. (2016). Birth and evolution of the desmoplastic small round-cell tumor. Seminars in Diagnostic Pathology. 33(5). 254–261. 3 indexed citations
17.
Fernández‐Pineda, Israel, et al.. (2014). Lower Extremity Fibro-Adipose Vascular Anomaly (FAVA): A New Case of a Newly Delineated Disorder. Annals of Vascular Diseases. 7(3). 316–319. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phani K. Davineni Breakdown of academic impact, for papers by Corey D. Chan Breakdown of academic impact, for papers by Salma Adham Breakdown of academic impact, for papers by Alethia Álvarez‐Cano Breakdown of academic impact, for papers by Hélène Boutroux Breakdown of academic impact, for papers by Yoshiyuki Nagumo Breakdown of academic impact, for papers by Bérengère Dadone‐Montaudié Breakdown of academic impact, for papers by Annick Chevalier-Place Breakdown of academic impact, for papers by Ka Su Breakdown of academic impact, for papers by Stuart Cramer
Rankless by CCL
2026